- Company Overview for PYRAMID PHARMA 8 LTD (14045637)
- Filing history for PYRAMID PHARMA 8 LTD (14045637)
- People for PYRAMID PHARMA 8 LTD (14045637)
- More for PYRAMID PHARMA 8 LTD (14045637)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
23 Oct 2024 | CS01 | Confirmation statement made on 23 October 2024 with updates | |
23 Oct 2024 | PSC01 | Notification of Parmjit Singh Notta as a person with significant control on 14 July 2023 | |
23 Oct 2024 | PSC07 | Cessation of Pyramid Pharma Pharmaceuticals Limited as a person with significant control on 14 July 2023 | |
14 May 2024 | CS01 | Confirmation statement made on 3 May 2024 with no updates | |
20 Mar 2024 | DISS40 | Compulsory strike-off action has been discontinued | |
19 Mar 2024 | GAZ1 | First Gazette notice for compulsory strike-off | |
18 Mar 2024 | AA | Accounts for a dormant company made up to 30 April 2023 | |
07 Aug 2023 | AD01 | Registered office address changed from 97 Carlton Avenue East Wembley Middlesex HA9 8LZ United Kingdom to 22 Old Dover Road London SE3 7BT on 7 August 2023 | |
07 Aug 2023 | TM01 | Termination of appointment of Jagjeet Singh Bhogal as a director on 14 July 2023 | |
07 Aug 2023 | AP01 | Appointment of Ms Faraheen Khalid as a director on 14 July 2023 | |
07 Aug 2023 | AP01 | Appointment of Mr Parmjit Singh Notta as a director on 14 July 2023 | |
10 May 2023 | CS01 | Confirmation statement made on 3 May 2023 with updates | |
03 May 2022 | CS01 | Confirmation statement made on 3 May 2022 with updates | |
03 May 2022 | PSC02 | Notification of Pyramid Pharma Pharmaceuticals Limited as a person with significant control on 14 April 2022 | |
22 Apr 2022 | PSC07 | Cessation of A Person with Significant Control as a person with significant control on 14 April 2022 | |
21 Apr 2022 | AP01 | Appointment of Mr Jagjeet Singh Bhogal as a director on 14 April 2022 | |
21 Apr 2022 | PSC09 | Withdrawal of a person with significant control statement on 21 April 2022 | |
20 Apr 2022 | TM01 | Termination of appointment of Michael Duke as a director on 13 April 2022 | |
13 Apr 2022 | NEWINC |
Incorporation
Statement of capital on 2022-04-13
|